Measles immunization: A descriptive review of the literature
DOI:
https://doi.org/10.33448/rsd-v12i12.44001Keywords:
Measles; Immunization; Adherence; Vaccination coverage; Public health.Abstract
Measles is an exanthematic disease, characterized by the occurrence of symptoms such as fever and maculopapular rash, and may be associated with these coughs, runny nose and conjunctivitis. It is a notifiable disease, which is essentially prevented by vaccination. Despite this fact, there is a constant decrease in vaccination in Brazil. Thus, the objective of this study was to conduct an integrative literature review in the SciELO, PubMed and VHL databases, using the descriptors the words: "measles", immunization", "public health" and "Brazil", in order to analyze the status of measles vaccination coverage, and understand what are the factors that interfere with the success of disease prevention campaigns. As a result, 93 articles were found, so that after analysis, according to the established inclusion criteria, 8 articles were selected for the sample of this study. The selected articles show that there was a considerable decrease in measles vaccination rates, so that the analyses varied according to the time frame described in each study. The findings demonstrate that strategies are needed to increase vaccination coverage against measles, especially with regard to vaccine hesitation by the population, which influences their adherence to the vaccine. Moreover, it was evident how socioeconomic disparities also impact vaccination coverage rates. It can be concluded, therefore, that the theme besides pertinent is quite current, so that the resurgence of measles is characterized as a public health problem.
References
Brasil. (2015). Programa Nacional de Imunizações. Coberturas vacinais no Brasil. Período: 2010 - 2014. Brasília: Ministério da Saúde. https://portalarquivos2.saude.gov.br/images/pdf/2017/agosto/17/AACOBERTURAS- VACINAIS-NO-BRASIL---2010-2014.pdf.
Brasil. (2018). Informe Epidemiológico n. 23, 17 de setembro de 2018. Situação do Sarampo no Brasil. Brasília: Ministério da Saúde. https://portalarquivos2.saude.gov.br/images/pdf/2018/setembro/19/informe-sarampo- 23.pdf.
Brasil. (2019). Informe Epidemiológico n. 36, 24 de janeiro de 2019. Situação do Sarampo no Brasil. Brasília: Ministério da Saúde. https://portalarquivos2.saude.gov.br/images/pdf/2019/janeiro/28/Informe-Sarampo- n36-24jan19aed.pdf.
Brasil. (2019). Ministério da Saúde. Situação do sarampo no Brasil – 2019. https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/svsa/raiva/be-vol-be-50-no-35-situacao-da-raiva-no-brasil-e-recomendacoes-quanto-ao-uso-dos-imunobiologicos.pdf.
Brasil. (2021). Ministério da Saúde. Informe quinzenal do sarampo – Brasil, semanas epidemiológicas 43 de 2020 a 1 de 2021. https://www.gov.br/saude/pt-br/media/pdf/2021/fevereiro/11/boletim_epidemiologico_svs_4.
Costa, N. R. et al. (2020). Measles epidemiological profile in Brasil from 2013 to 2018. Revista da Associação Médica Brasileira. 66 (5): 9-13.
Dubé, E. et al. (2015). Hesitância da Vacina, Recusa da Vacina e o Movimento Anti-Vacina: Influência, Impacto e Implicações. Vacinas Rev Especialistas. 14 (1): 99-117.
Elidio, G. A. et al. (2019). Measles outbreak: preliminary report on a case series of the first 8,070 suspected cases, Manaus, Amazonas state, Brazil, February to November 2018. Euro Surveill. 24: 2-7.
Fernandes, E. G. et al. (2013). Surto de sarampo na região metropolitana de Campinas, SP. Rev Saúde Pública. 47 (6): 1213-1217.
Ferreira, R. S. B. et al. (2019). Correlação entre cobertura vacinal e notificações por sarampo no Distrito Federal. Revista Eletrônica Acervo Saúde. 11 (17): 1-8. https://www.acervomais.com.br/index.php/saude/article/view/1654/945.
Frade, J. M. G. et al. (2017). A enfermagem e a vacinação: evolução do cumprimento da vacina combinada contra o sarampo, parotidite e rubéola. Revista de Enfermagem Referência Coimbra. IV (13): 9-18. http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0874- 02832017000200002&lng=pt&nrm=iso.
Lane, S. et al. (2018). Hesitação de Vacinas em todo o Mundo: Análise de Três Anos de Dados do Formulário de Relatório Conjunto OMS/UNICEF-2015-2017. Vacina. 36 (26): 3861-3867.
Makarenko, C. et al. (2022). Identificação de áreas de risco e fatores associados à epidemia de sarampo de 2019 no Estado de São Paulo, Brasil. Cadernos de Saúde Pública. 38 (10): 6-11.
Moura, A. D. A. et al. (2018). Estratégias e resultados da vacinação no enfrentamento da epidemia de sarampo no estado do Ceará, 2013-2015. Epidemiol. Serv. Saúde. 27 (1): 2016-34310.
Oliveira, I. S. et al. (2022). Anti-vaccination movements in the world and in Brazil. Rev. Soc. Bras. Med. 55: 2-7.
OMS. (2019). Ten threats to global health in 2019. Organização Mundial da Saúde (OMS). https://www.who.int/news-room/spotlight/ten-threats-to- global-health-in-2019.
OMS. (2020). Supplement to who Vaccine Position Papers. Guideline develelopment Group. Organização Mundial da Saúde (OMS). World Health Organization. https://cdn.who.int/media/docs/default-source/immunization/position_paper_documents/position-paper-process.pdf?sfvrsn=bbb956dc_2&download=true.
Pacheco, F. C. et al. (2020). Measles-containing vaccines in Brazil: Coverage, homogeneity of coverage and associations with contextual factors at municipal level. Vaccine. 18;38 (8):1881-1887.
Pamplona, Y. de A. P. et al. (2023). Spatial analysis of measles vaccination coverage in the State of São Paulo. BMC Public Health. 5;23 (1):29.
Sato, A. P. S. et al. (2023). Vacinação do sarampo no Brasil: onde estivemos e para onde vamos? Ciênc. saúde coletiva 28 (2): 353-360.
Silverio, M. F. et al. (2020). The emergence of vaccine hesitancy among upper-class Brazilians: Results from four birth cohorts. Vaccine. 1982–2015.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Bárbara Betzek Bertoncelli; Claudinei Mesquita da Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
